Halogenated Phenol Antimicrobial Composition
Summary
The USPTO published patent application US20260091002A1 filed by Industry Academic Cooperation Foundation of Yeungnam University for a halogenated phenol derivative composition with antimicrobial and antibiofilm activity against Staphylococcus aureus and pathogenic microorganisms. The application, filed June 10, 2025, covers the composition, methods of use, and treatment of biofilm-related infections.
What changed
Yeungnam University researchers disclosed a novel halogenated phenol derivative composition demonstrating antimicrobial and antibiofilm activity against Staphylococcus aureus and pathogenic microorganisms. Patent application US20260091002A1 was published April 2, 2026, naming inventors Jintae Lee, Jin-Hyung Lee, and Olanrewaju Abdulrauf Olalekan under Application No. 19232973, with CPC classifications including A61K 31/055 and A61P 31/04.
This publication protects the novel chemical composition and its therapeutic applications. Parties interested in licensing the technology or developing related antimicrobial products should monitor the application prosecution status through the USPTO. The composition may have applications in treating drug-resistant bacterial infections and biofilm-associated conditions.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITION FOR ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY CONTAINING HALOGENATED PHENOL DERIVATIVE AS ACTIVE INGREDIENT
Application US20260091002A1 Kind: A1 Apr 02, 2026
Assignee
Industry Academic Cooperation Foundation of Yeungnam University
Inventors
Jintae LEE, Jin-Hyung LEE, OLANREWAJU ABDULRAUF OLALEKAN
Abstract
The present disclosure relates to an antimicrobial and antibiofilm composition containing a halogenated phenol derivative as an active ingredient, and more specifically, to an antibiofilm composition against Staphylococcus aureus or pathogenic microorganisms, an antimicrobial composition, and a composition for treating an infection caused by a biofilm of Staphylococcus aureus or pathogenic microorganisms, containing a halogenated phenol derivative or a pharmaceutically acceptable salt thereof having excellent antimicrobial and antibiofilm activity against Staphylococcus aureus and/or pathogenic microorganisms as an active ingredient.
CPC Classifications
A61K 31/055 A61K 31/43 A61K 31/65 A61K 31/7036 A61K 38/14 A61P 31/04
Filing Date
2025-06-10
Application No.
19232973
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.